nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00796	0.00804	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00777	0.00785	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00765	0.00773	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—KCNJ5—adrenal gland cancer	0.00758	0.00766	CbGpPWpGaD
Oxazepam—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00755	0.00763	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00724	0.00732	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—KCNJ5—adrenal gland cancer	0.00723	0.0073	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—KCNJ5—adrenal gland cancer	0.00723	0.0073	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00715	0.00722	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00696	0.00703	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00654	0.00661	CbGpPWpGaD
Oxazepam—CYP3A43—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00654	0.00661	CbGpPWpGaD
Oxazepam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00647	0.00653	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00635	0.00642	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00624	0.0063	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00613	0.00619	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00609	0.00615	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00598	0.00604	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—KCNJ5—adrenal gland cancer	0.00595	0.00601	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—KCNJ5—adrenal gland cancer	0.00586	0.00592	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—KCNJ5—adrenal gland cancer	0.00555	0.00561	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—KCNJ5—adrenal gland cancer	0.00548	0.00554	CbGpPWpGaD
Oxazepam—CYP3A43—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0053	0.00536	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00523	0.00528	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00504	0.00509	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—KCNJ5—adrenal gland cancer	0.00501	0.00506	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—KCNJ5—adrenal gland cancer	0.00487	0.00492	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—MED12—adrenal gland cancer	0.00484	0.00489	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00481	0.00486	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00481	0.00486	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—KCNJ5—adrenal gland cancer	0.00478	0.00483	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00474	0.00479	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0047	0.00475	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—KCNJ5—adrenal gland cancer	0.00467	0.00472	CbGpPWpGaD
Oxazepam—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00459	0.00464	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—KCNJ5—adrenal gland cancer	0.00458	0.00463	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00401	0.00405	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00396	0.004	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0039	0.00394	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00379	0.00383	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00369	0.00373	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00365	0.00368	CbGpPWpGaD
Oxazepam—UGT2B15—Biological oxidations—POMC—adrenal gland cancer	0.00364	0.00368	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00362	0.00365	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00362	0.00365	CbGpPWpGaD
Oxazepam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00354	0.00357	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00333	0.00337	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00327	0.0033	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SDHB—adrenal gland cancer	0.00326	0.00329	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00324	0.00327	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00318	0.00321	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00313	0.00316	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00311	0.00314	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00305	0.00308	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00298	0.00301	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00293	0.00296	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—PRKACA—adrenal gland cancer	0.0029	0.00293	CbGpPWpGaD
Oxazepam—CYP3A43—Biological oxidations—POMC—adrenal gland cancer	0.00282	0.00285	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00278	0.0028	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—PRKACA—adrenal gland cancer	0.00277	0.0028	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—PRKACA—adrenal gland cancer	0.00277	0.0028	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00274	0.00277	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00272	0.00275	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00267	0.00269	CbGpPWpGaD
Oxazepam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00263	0.00266	CbGpPWpGaD
Oxazepam—Flurbiprofen—PTGS2—adrenal gland cancer	0.0026	0.256	CrCbGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00259	0.00262	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00259	0.00262	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00258	0.0026	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SDHB—adrenal gland cancer	0.00252	0.00254	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00251	0.00253	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00244	0.00247	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00243	0.00246	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00239	0.00242	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00235	0.00237	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00233	0.00236	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00229	0.00232	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—PRKACA—adrenal gland cancer	0.00228	0.0023	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—PRKACA—adrenal gland cancer	0.00225	0.00227	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00219	0.00221	CbGpPWpGaD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00214	0.00216	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00213	0.00216	CbGpPWpGaD
Oxazepam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00213	0.00216	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—PRKACA—adrenal gland cancer	0.00213	0.00215	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0021	0.00212	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—RRM1—adrenal gland cancer	0.0021	0.00212	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SDHD—adrenal gland cancer	0.0021	0.00212	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—PRKACA—adrenal gland cancer	0.0021	0.00212	CbGpPWpGaD
Oxazepam—Clobazam—ABCB1—adrenal gland cancer	0.00206	0.203	CrCbGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00204	0.00206	CbGpPWpGaD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00203	0.00205	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.002	0.00202	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00199	0.00201	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00196	0.00198	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00195	0.00197	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00195	0.00197	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—PRKACA—adrenal gland cancer	0.00192	0.00194	CbGpPWpGaD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0019	0.00192	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—PRKACA—adrenal gland cancer	0.00187	0.00188	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—PRKACA—adrenal gland cancer	0.00183	0.00185	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—BAD—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—PRKACA—adrenal gland cancer	0.00179	0.00181	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—PRKACA—adrenal gland cancer	0.00176	0.00177	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00175	0.00176	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00171	0.00173	CbGpPWpGaD
Oxazepam—Nitrazepam—ABCB1—adrenal gland cancer	0.0017	0.168	CrCbGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00168	0.0017	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00167	0.00169	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.00166	0.00168	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00164	0.00166	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—RRM1—adrenal gland cancer	0.00162	0.00164	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SDHD—adrenal gland cancer	0.00162	0.00164	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0016	0.00162	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00158	0.0016	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—MED12—adrenal gland cancer	0.00157	0.00158	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—BRAF—adrenal gland cancer	0.00157	0.00158	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00156	0.00158	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00154	0.00156	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00154	0.00155	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0015	0.00151	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—BRAF—adrenal gland cancer	0.00149	0.00151	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—BRAF—adrenal gland cancer	0.00149	0.00151	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00149	0.0015	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00149	0.0015	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.00148	0.0015	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00148	0.00149	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00144	0.00145	CbGpPWpGaD
Oxazepam—Midazolam—ABCB1—adrenal gland cancer	0.0014	0.138	CrCbGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00135	0.00136	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—POMC—adrenal gland cancer	0.00135	0.00136	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00131	0.00133	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.0013	0.00131	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00129	0.0013	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00127	0.00128	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00127	0.00128	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00126	0.00127	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00124	0.00125	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00124	0.00125	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—BRAF—adrenal gland cancer	0.00123	0.00124	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00123	0.00124	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—BRAF—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MED12—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SDHB—adrenal gland cancer	0.00121	0.00122	CbGpPWpGaD
Oxazepam—Diazepam—ABCB1—adrenal gland cancer	0.0012	0.118	CrCbGaD
Oxazepam—Clozapine—ABCB1—adrenal gland cancer	0.00119	0.117	CrCbGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00118	0.0012	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00118	0.0012	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00118	0.00119	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—BRAF—adrenal gland cancer	0.00115	0.00116	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00114	0.00116	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PRKACA—adrenal gland cancer	0.00114	0.00115	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00113	0.00115	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—BRAF—adrenal gland cancer	0.00113	0.00114	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00113	0.00114	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00108	0.00109	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—BRAF—adrenal gland cancer	0.00103	0.00105	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00103	0.00104	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.00101	0.00102	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—BRAF—adrenal gland cancer	0.00101	0.00102	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.001	0.00101	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000994	0.001	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—BRAF—adrenal gland cancer	0.000987	0.000997	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000985	0.000995	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000979	0.000989	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000976	0.000986	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00097	0.00098	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000968	0.000978	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—BRAF—adrenal gland cancer	0.000964	0.000974	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000962	0.000972	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000961	0.000971	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SDHD—adrenal gland cancer	0.000956	0.000966	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—RRM1—adrenal gland cancer	0.000956	0.000966	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000952	0.000962	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000949	0.000959	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—BRAF—adrenal gland cancer	0.000947	0.000956	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000944	0.000954	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000927	0.000936	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GNAS—adrenal gland cancer	0.000926	0.000935	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000915	0.000924	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000909	0.000919	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ABCB1—adrenal gland cancer	0.000908	0.000918	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000898	0.000907	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000885	0.000894	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PRKACA—adrenal gland cancer	0.000883	0.000892	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000837	0.000845	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.000827	0.000836	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000825	0.000834	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000821	0.00083	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.00082	0.000828	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000813	0.000821	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000798	0.000807	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000798	0.000806	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000785	0.000793	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000783	0.000791	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000779	0.000787	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SDHD—adrenal gland cancer	0.000777	0.000785	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—RRM1—adrenal gland cancer	0.000777	0.000785	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00077	0.000778	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000765	0.000773	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000765	0.000773	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000751	0.000759	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000733	0.000741	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000718	0.000725	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GNAS—adrenal gland cancer	0.000715	0.000723	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MED12—adrenal gland cancer	0.000713	0.00072	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ABCB1—adrenal gland cancer	0.000702	0.000709	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000669	0.000676	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000656	0.000663	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.000654	0.00066	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.000654	0.00066	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—POMC—adrenal gland cancer	0.000623	0.00063	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MED12—adrenal gland cancer	0.000579	0.000585	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	0.00052	0.000526	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000518	0.000523	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTGS2—adrenal gland cancer	0.000497	0.000502	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000487	0.000492	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—POMC—adrenal gland cancer	0.000482	0.000487	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000472	0.000477	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000472	0.000477	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	0.000423	0.000427	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GNAS—adrenal gland cancer	0.000422	0.000426	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	0.000414	0.000418	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000413	0.000417	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTGS2—adrenal gland cancer	0.000384	0.000388	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000381	0.000385	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000356	0.000359	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000352	0.000356	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GNAS—adrenal gland cancer	0.000343	0.000346	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000341	0.000344	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	0.000336	0.00034	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000288	0.000291	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—POMC—adrenal gland cancer	0.000284	0.000287	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000283	0.000286	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000257	0.00026	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—POMC—adrenal gland cancer	0.000231	0.000233	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	0.000226	0.000229	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.00022	0.000222	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.00022	0.000222	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000208	0.00021	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000204	0.000206	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000194	0.000196	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	0.000184	0.000186	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000164	0.000165	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000155	0.000156	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.00014	0.000142	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000119	0.000121	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000112	0.000113	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.68e-05	9.78e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	9.5e-05	9.6e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.52e-05	6.59e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.2e-05	5.25e-05	CbGpPWpGaD
